- Home
- AMPY vs PRQR Comparison
AMPY vs PRQR Comparison
Compare AMPY & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- PRQR
- Stock Information
- Founded
- AMPY 2011
- PRQR 2012
- Country
- AMPY United States
- PRQR Netherlands
- Employees
- AMPY N/A
- PRQR N/A
- Industry
- AMPY Oil & Gas Production
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- PRQR Health Care
- Exchange
- AMPY Nasdaq
- PRQR Nasdaq
- Market Cap
- AMPY 140.8M
- PRQR 179.1M
- IPO Year
- AMPY 2011
- PRQR 2014
- Fundamental
- Price
- AMPY $3.46
- PRQR $2.35
- Analyst Decision
- AMPY Strong Buy
- PRQR Strong Buy
- Analyst Count
- AMPY 2
- PRQR 8
- Target Price
- AMPY $10.25
- PRQR $8.88
- AVG Volume (30 Days)
- AMPY 1.4M
- PRQR 357.1K
- Earning Date
- AMPY 08-06-2025
- PRQR 08-07-2025
- Dividend Yield
- AMPY N/A
- PRQR N/A
- EPS Growth
- AMPY N/A
- PRQR N/A
- EPS
- AMPY 0.39
- PRQR N/A
- Revenue
- AMPY $290,431,100.00
- PRQR $21,212,711.00
- Revenue This Year
- AMPY $2.88
- PRQR N/A
- Revenue Next Year
- AMPY $50.86
- PRQR N/A
- P/E Ratio
- AMPY $8.77
- PRQR N/A
- Revenue Growth
- AMPY N/A
- PRQR 85.91
- 52 Week Low
- AMPY $2.27
- PRQR $1.07
- 52 Week High
- AMPY $8.15
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- AMPY 52.75
- PRQR 66.90
- Support Level
- AMPY $3.12
- PRQR $2.10
- Resistance Level
- AMPY $3.47
- PRQR $2.18
- Average True Range (ATR)
- AMPY 0.21
- PRQR 0.13
- MACD
- AMPY -0.02
- PRQR 0.01
- Stochastic Oscillator
- AMPY 33.54
- PRQR 56.92
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.